TP53 and neoplasm: Missense mutations cause mutant p53 protein to lose its wild-type functions (LOF) and acquire dominant-negative activities and endow mutant p53 with gain-of-function (GOF) capabilities that confer aggressive tumor behavior and drug resistance.